Fat-Soluble Vitamins in Advanced CKD/ESKD: A Review

Seminars in Dialysis

Volumn 25, Issue 3, 2012, Pages 334-343

  Holden, Rachel M ^a   Ki, Vincent ^b   Morton, Alexander Ross ^a   Clase, Catherine ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; HUMAN; NUTRITIONAL STATUS; RENAL REPLACEMENT THERAPY; VITAMIN DEFICIENCY;

AVITAMINOSIS; DIETARY SUPPLEMENTS; HUMANS; KIDNEY FAILURE, CHRONIC; NUTRITIONAL STATUS; RENAL DIALYSIS; VITAMINS;

EID: 84862082669     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2012.01084.x     Document Type: Article

References (106)

1. Rodrigues P, Goncalves C, Bairos V: Metabolic pathways and modulating effects of vitamin A. Curr Med Chem - Immun Endoc Metab Agents 4:119-142, 2004
2. Bernard A, Vyskocyl A, Mahieu P, Lauwerys R: Effect of renal insufficiency on the concentration of free retinol-binding protein in urine and serum. Clin Chim Acta 171(1):85-93, 1988
3. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vandium and Zinc. Washington, DC: The National Academies Press, 2001
4. Yatzidis H, Digenis P, Koutsicos D: Hypervitaminosis A in chronic renal failure after transplantation. Br Med J 2(6043):1075, 1976
5. Bobbert T, Jens R, Schwarz F, Mai K, Henze A, Pfeiffer AFG, Scheigert FJ, Spranger J: Relation between retinol, retinol-binding protein 4, transthyretin and carotic intima media thickness. Atherosclerosis 213(2):549-551, 2010
6. Gotloib L, Sklan D, Mines M: Hemodialysis. Effect on plasma levels of vitamin A and carotenoid. JAMA 239(8):751, 1978
7. Bonnefont-Rousselot D, Jaudon MC, Issad B, Cacoub P, Congy F, Jardel C, Delattre J, Jacobs C: Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 12(7):1399-1405, 1997
8. Abahusain MA, Al-Nahedh NN: The biochemical status of vitamin A and alpha-tocopherol during different stages of renal disease and its relationship to diabetes. Saudi J Kidney Dis Transplant 13:18-23, 2002
9. Fishbane S, Frei GL, Finger M, Dressler R, Silbiger S: Hypervitaminosis A in two hemodialysis patients. Am J Kidney Dis 25(2):346-349, 1995
10. Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, Snetselaar LG, Chen Z: Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study. Am J Clin Nutr 89(1):323-330, 2009
11. Cundy T, Earnshaw M, Heynen G, Kanis JA: Vitamin A and hyperparathyroid bone disease in uremia. Am J Clin Nutr 38(6):914-920, 1983
12. Holick MF: Vitamin D Deficiency. N Engl J Med 357(3):266-281, 2007
13. Bikle DD: Vitamin D : newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 21:375-384, 2010
14. Deb DK, Sun T, Wong KE, Zhang Z, Ning G, Zhang Y, Kong J, Shi H, Chang A, Li YC: Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. Kidney Int 77(11):1000-1009, 2010
15. Li M, Batuman V: Vitamin D: a new hope for chronic kidney disease? Kidney Int 76(12):1219-1221, 2009
16. Park JW, Bae EH, Kim IJ, Ma SK, Choi C, Lee J, Kim SW: Paricalcitol attenuates cyclosporine-induced kidney injury in rats. Kidney Int 77(12):1076-1085, 2010
17. Zhang Y, Kong J, Deb DK, Chang A, Li YC: Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system. J Am Soc Nephrol 21:966-973, 2010
18. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC: Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 105(41):15896-15901, 2008
19. Adams JS, Hewison M: Update in vitamin D. J Clin Endocrinol Metab 95:471-478, 2010
20. White JH: Vitamin D as an inducer of cathelicidin antimicrobial peptide expression : Past, present and future. J Steroid Biochem Mol Biol 121(1-2):234-238, 2010
21. Prosser DE, Jones G: Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29(12):664-673, 2004
22. Kumar V, Kujubu D, Sim JJ, Rasgon S, Yang PS: Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J Nephrol 24(15):98-105, 2010
23. Jones G: Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 88(2):582S-586S, 2008
24. Armas L, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89(11):5387-5391, 2004
25. Trang HM, Cole DE, Rubin L, Pierratos A, Siu S, Vieth R: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68(4):854-858, 1998
26. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannenbaum AD: Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 93(3):677-681, 2008
27. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA: Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 96(3):E447-E452, 2011
28. Ross AC, Taylor CL, Yaktine CL, Del Valle HB: Institute of Medicine - Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press, 2011
29. Heaney RP: Vitamin D: criteria for safety and efficacy. Nutr Rev 66(10 Suppl. 2):S178-S181, 2008
30. Heaney RP, Armas L, Shary JR, Bell NH, Binkley N, Hollis BW: 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 87(6):1738-1742, 2008
31. Gallegos-Bayas G, Pascual-Pareja JF, Sanchez-Nino MD, Manzarbeitia F, Ortiz A: Undetectable serum calcidiol: not everything that glitters is gold. Clin Kidney J 5:37-40, 2012
32. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B: Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293(18):2257, 2005
33. Yetley E: Assessing the vitamin D status of the US population. Am J Clin Nutr 88(2):558S-564S, 2008
34. Bolland MJ, Grey AB, Ames RW, Mason BH, Horne AM, Gamble GD, Reid IR: The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr 86(4):959-964, 2007
35. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W: Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Int Med 168(12):1340-1349, 2008
36. Giovannucci E, Liu Y, Hollis BW, Rimm EB: 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Int Med 168(11):1174-1180, 2008
37. Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Helivaara M, Impivaara O, Reunanen A: Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170(8):1032-1039, 2009
38. Melamed ML, Michos ED, Post W, Astor B: 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Int Med 168(15):1629-1637, 2008
39. Pilz S, M+ñrz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H: Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 93(10):3927-3935, 2008
40. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 117(4):503-511, 2008
41. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, Fournier A, Massy Z: Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 4(6):1128-1135, 2009
42. Blair D, Byham-Gray L, Lewis E, McCaffrey S: Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Renal Nutr 18(4):375-382, 2008
43. Clayton P, Singer R: 25-Hydroxyvitamin D levels in prevalent Australian dialysis patients. Nephrology (Carlton, Vic) 14(6):554-559, 2009
44. Cuppari L, Carvalho AzB, Draibe S: Vitamin D status of chronic kidney disease patients living in a sunny country. J Renal Nutr 18(5):408-414, 2008
45. Gonzílez E, Sachdeva A, Oliver D, Martin KJ: Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24(5):503-510, 2004
46. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C: Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant 23(11):3670-3676, 2008
47. Laclair R, Hellman R, Karp S, Kraus M, Ofner S, Li Q, Graves K, Moe S: Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45(6):1026-1033, 2005
48. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams L, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71(1):31-38, 2007
49. Mehrotra R, Kermah D, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC: Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 76(9):977-983, 2009
50. Pecovnik-Balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M: Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients. Therap Apher Dial 13(4):268-272, 2009
51. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW: Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105(3):c132-c138, 2007
52. Shah N, Bernardini J, Piraino B: Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Peritoneal Dial Int 25(4):362-366, 2005
53. Taskapan H, Ersoy FF, Passadakis PS, Tam P, Memmos DE, Katopodis KP, Ozener C, Akcicek F, Camsari T, Ates K, Ataman R, Vlachojannis JG, Dombros NA, Utas C, Akpolat T, Bozfakioglu S, Wu G, Karayaylali I, Arinsoy T, Stathakis CP, Yavuz M, Tsakiris DJ, Dimitriades AD, Yilmaz ME, Gültekin M, Oreopoulos DG: Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol 66(4):247-255, 2006
54. Valle EDEL, Negri AL, Aguirre C, Fradinger E, Zanchetta JR: Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 11:315-321, 2007
55. Susantitaphong P, Jaber BL: Potential interaction between Sevelamer and fat-soluble vitamins: A Hypothesis. Am J Kidney Dis 59(2):165-167, 2012
56. Inaguma D, Nagaya H, Hara K, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Kurata K: Relationship between serum 1, 25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol 12(2):126-131, 2008
57. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75(1):88-95, 2009
58. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo C, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72(8):1004-1013, 2007
59. Garcia-Canton C, Bosch E, Ramirez A, Gonzalez Y, Auyanet I, Guerra R, Perez MA, Fernandez E, Toledo A, Lago M, Checa MD: Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant 26(7):2250-2256, 2011
60. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS: 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20(8):1805-1812, 2009
61. Hur SJ, Kim DM, Lim KH, Yoon SH, Chung HC, Lee JS, Park J: Vitamin D levels and their relationship with cardiac biomarkers in chronic hemodialysis patients. J Korean Med Sci 24(Suppl. 1):S109-S114, 2009
62. Obineche EN, Saadi H, Benedict S, Pathan JY, Frampton CM, Nicholls MG: Interrelationships between B-type natriuretic peptides and vitamin D in patients on maintenance peritoneal dialysis. Peritoneal Dial Int 28(6):617-621, 2008
63. London GrM, Gurin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18(2):613-620, 2007
64. Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P: 25-Hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 20(12):2631-2639, 2009
65. Stavroulopoulos A, Porter CJ, Roe SD, Hosking DJ, Cassidy MJD: Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4. Nephrology 13:63-67, 2008
66. Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT, Tangpricha V: Cholecalciferol (Vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 14(1):10-17, 2008
67. Dogan E, Erkoc R, Sayarlioglu H, Soyoral Y, Dulger H: Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients. Renal Fail 30(4):407-410, 2008
68. Oksa A, Spustova V, Krivosikova Z, Gazdikova K, Fedelesova V, Lajdova I, Stefikova K, Bernasovska G, Zilinska Z, Dzurik R: Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res 31(5):322-329, 2008
69. Wissing KM, Broeders N, Moreno-Reyes R, Gervy C, Stallenberg B, Abramowicz D: A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 79(1):108-115, 2005
70. Kovesdy CP, Lu JL, Malakauskas SM, Andress DL, Kalantar-Zadeh K, Ahmadzadeh S: Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis 59(1):58-66, 2012
71. Kim MJ, Frankel AH, Donaldson M, Darch SJ, Pusey CD, Hill PD, Mayr M, Tam FW: Oral cholecalciferol decreases albuminuria and urinary TGF-beta1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int 80(8):851-860, 2011
72. Jones G: Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin Dial 23(3):239-243, 2010
73. Hacquebard M, Carpentier YA: Vitamin E: absorption, plasma transport and cell uptake. [Review] [63 refs]. Curr Opin Clin Nutr Metab Care 8(2):133-138, 2005
74. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR; HOPE and HOPE-TOO Trial Investigators: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293(11):1338-1347, 2005
75. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN: gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA 97(21):11494-11499, 2000
76. Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B: Vitamins E and C are safe across a broad range of intakes. [Review] [95 refs]. Am J Clin Nutr 81(4):736-745, 2005
77. Galli F, Floridi AG, Floridi A, Buoncristiani U: Accumulation of vitamin E metabolites in the blood of renal failure patients. Clin Nutr 23(2):205-212, 2004
78. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM: Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol 28(3):397-404, 2008
79. Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G: Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int 64(3):978-991, 2003
80. Sundl I, Roob JM, Meinitzer A, Tiran B, Khoschsorur G, Haditsch B, Holzer H, Winklhofer-Roob BM: Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress. Peritoneal Dial Int 29(1):89-101, 2009
81. Galli F, Buoncristiani U, Conte C, Aisa C, Floridi A: Vitamin E in uremia and dialysis patients. Ann N Y Acad Sci 1031:348-351, 2004
82. Traber MG, Frei B, Beckman JS: Vitamin E revisited: do new data validate benefits for chronic disease prevention? [Review] [82 refs]. Curr Opin Lipidol 19(1):30-38, 2008
83. Kamgar M, Zaldivar F, Vaziri ND, Pahl MV: Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. J Natl Med Assoc 101(4):336-344, 2009
84. Antoniadi G, Eleftheriadis T, Liakopoulos V, Kakasi E, Kartsios C, Passadakis P, Vargemezis V: Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Therap Apher Dial 12(3):237-242, 2008
85. Lu L, Erhard P, Salomon RG, Weiss MF: Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial.[Erratum appears in Am J Kidney Dis. 2007 Nov;50(5):899]. Am J Kidney Dis 50(2):305-313, 2007
86. Uzum A, Toprak O, Gumustas MK, Ciftci S, Sen S: Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis. J Nephrol 19(6):739-745, 2006
87. Khajehdehi P, Mojerlou M, Behzadi S, Rais-Jalali GA: A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant 16(7):1448-1451, 2001
88. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356(9237):1213-1218, 2000
89. Fouque D, Vennegoor M, ter WP, Wanner C, Basci A, Canaud B, Haage P, Konner K, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Tordoir J, Vanholder R: EBPG guideline on nutrition. Nephrol Dial Transplant Suppl 2:ii45-87, 2007
90. Reed A, Cho YJ, Coombes JS, Fassett RG: Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patients. BMC Nephrol 10:32, 2009
91. Pilkey RM, Morton AR, Boffa MB, Noordhof C, Day AG, Su Y, Miller LM, Koschinsky ML, Booth SL: Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 49(3):432-439, 2007
92. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B: Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 93(4):1217-1223, 2008
93. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ: Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. [Review] [42 refs]. Arch Intern Med 166(12):1256-1261, 2006
94. Shea MK, Dallal GE, Dawson-Hughes B, Ordovas JM, O'Donnell CJ, Gundberg CM, Peterson JW, Booth SL: Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 88(2):356-363, 2008
95. Vermeer C, Shearer MJ, Zittermann A, Bolton-Smith C, Szulc P, Hodges S, Walter P, Rambeck W, Stocklin E, Weber P: Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. [Review] [89 refs]. Eur J Nutr 43(6):325-335, 2004
96. Booth SL, Martini L, Peterson JW, Saltzman E, Dallal GE, Wood RJ: Dietary phylloquinone depletion and repletion in older women. J Nutr 133(8):2565-2569, 2003
97. Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL: Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol 5(4):590-597, 2010
98. Booth SL, Suttie JW: Dietary intake and adequacy of vitamin K. [Review] [47 refs]. J Nutr 128(5):785-788, 1998
99. Holden RM, Iliescu E, Morton AR, Booth SL: Vitamin K status of Canadian peritoneal dialysis patients. Peritoneal Dial Int 28(4):415-418, 2008
100. Westenfeld R, Krueger T, Schlieper G, Cranenburg ECM, Magdeleyns EJ, Heidenreich S, Holzmann S, Vermeer C, Jahnen-Dechent W, Ketteler M, Floege J, Schurgers LJ: Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: A randomized trial. Am J Kidney Dis 59(2):186-195, 2012
101. Stankowiak-Kulpa H, Krzyzanowska P, Koziol L, Grzymistawski M, Wannic-Kossowska M, Moczko J, Walkowiak J: Vitamin K status in peritoneally dialyzed patients with chronic kidney disease. Acta Biochem Polon 58:617-620, 2011
102. Kohlmeier M, Saupe J, Shearer MJ, Schaefer K, Asmus G: Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int 51(4):1218-1221, 1997
103. Nakashima A, Yorioka N, Doi S, Masaki T, Ito T, Harada S: Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels. Bone 34(3):579-583, 2004
104. Sugimoto T, Yamakado M, Matsushita K, Iwamoto T, Tagawa H: Pharmacodynamics of menatetrenone and effects on bone metabolism in continuous ambulatory peritoneal dialysis patients. J Int Med Res 30(6):566-575, 2002
105. Reichel H: No effect of vitamin K1 supplementation on biochemical bone markers in haemodialysis patients. Nephrol Dial Transplant 14(1):249-250, 1999
106. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: The National Academies, 2000